ciprofloxacin has been researched along with acetylcysteine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (23.81) | 29.6817 |
| 2010's | 12 (57.14) | 24.3611 |
| 2020's | 4 (19.05) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bharate, SS; Vishwakarma, RA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abouelhassan, Y; Bai, F; Burch, GM; Garrison, AT; Huigens, RW; Jin, S; Kallifidas, D; Luesch, H; Nguyen, MT; Norwood, VM; Rolfe, M | 1 |
| Assy, N; Gefen, H; Hussein, O; Schlesinger, S | 1 |
| Choe, WT; Murray, MT; Roberson, JB; Stidham, KR | 1 |
| Abd El-Baky, RM; Abolella, HA; El-Feky, MA; El-Rehewy, MS; Gad, GF; Hassan, MA | 1 |
| Akkiz, H; Cosar, A; Kece, C; Ozdil, B; Sandikci, M | 1 |
| Liu, Y; Zhao, T | 1 |
| Ayakar, KG; Conlin, AE; Doyle, P; Lea, J; Noble, M; Rennie, R; Restelli, V; Schreiber, WE; Sekirov, I; Turnbull, L; Westerberg, BD | 1 |
| Jang, EY; Lee, JY; Moon, JH; Shim, KS | 1 |
| Esteban, J; García-Pedrazuela, M; Mahillo-Fernandez, I; Muñoz-Egea, MC | 1 |
| Emir, D; Gocer, H; Kaplan, S; Onger, ME | 1 |
| Blázquez, J; Costas, C; Galhardo, RS; Rodríguez-Beltrán, J; Rodríguez-Rojas, A; Rodríguez-Rosado, AI; Valencia, EY | 1 |
| Elgaher, WAM; Haupenthal, J; Hirsch, AKH; Lababidi, N; Ofosu Kissi, E; Rades, T; Schneider, M; Schwarz, BC; Sigal, V | 1 |
| de Souza Carvalho-Wodarz, C; Lababidi, N; Lehr, CM; Montefusco-Pereira, CV; Schneider, M | 1 |
| Aggelopoulos, S; Bitsianis, S; Chatzakis, C; Gekas, C; Gkiouliava, A; Ioannidis, O; Konstantaras, D; Kyziridis, D; Makrantonakis, A; Mantzoros, I; Miliaras, D; Parpoudi, S | 1 |
| Aldogan, EH; Hacioglu, M; Yilmaz, FN | 1 |
| Chan, CY; Conley, SF; Daniel, SJ; Grenier, K; Linn, DT; Partain, MP; Salameh, S; Sayegh, J; Wurzba, SDS | 1 |
1 review(s) available for ciprofloxacin and acetylcysteine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for ciprofloxacin and acetylcysteine
| Article | Year |
|---|---|
Potential benefits of combined N-acetylcysteine and ciprofloxacin therapy in partial biliary obstruction.
Topics: Acetylcysteine; Aged; Anti-Infective Agents; Bile Ducts; Bilirubin; C-Reactive Protein; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Cholestasis; Ciprofloxacin; Dilatation, Pathologic; Double-Blind Method; Drug Synergism; Expectorants; Female; Humans; Male; Middle Aged; Pilot Projects; Severity of Illness Index; Sphincterotomy, Endoscopic; Ultrasonography | 2010 |
19 other study(ies) available for ciprofloxacin and acetylcysteine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.
Topics: Biofilms; Carbon-13 Magnetic Resonance Spectroscopy; Drug Resistance, Bacterial; Drug Screening Assays, Antitumor; Halogens; HeLa Cells; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenazines; Proton Magnetic Resonance Spectroscopy; Structure-Activity Relationship | 2016 |
The beneficial effect of N-acetylcysteine and ciprofloxacin therapy on the outcome of ischemic fulminant hepatic failure.
Topics: Acetylcysteine; Ciprofloxacin; Drug Therapy, Combination; Follow-Up Studies; Free Radical Scavengers; Humans; Ischemia; Liver; Liver Failure, Acute; Male; Middle Aged; Nucleic Acid Synthesis Inhibitors | 2007 |
N-Acetylcysteine as an adjunct for refractory ear infections.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Inflammatory Agents; Antiviral Agents; Audiometry; Audiometry, Pure-Tone; Child; Ciprofloxacin; Dexamethasone; Drug Combinations; Drug Resistance; Ear Diseases; Female; Humans; Infections; Male; Middle Aged; Pharmaceutical Solutions; Pilot Projects | 2007 |
Effect of ciprofloxacin and N-acetylcysteine on bacterial adherence and biofilm formation on ureteral stent surfaces.
Topics: Acetylcysteine; Anti-Bacterial Agents; Bacteria; Bacterial Physiological Phenomena; Biofilms; Ciprofloxacin; Stents; Ureter | 2009 |
N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa.
Topics: Acetylcysteine; Anti-Bacterial Agents; Biofilms; Biomass; Ciprofloxacin; Colony Count, Microbial; Drug Interactions; Humans; Microbial Sensitivity Tests; Microbial Viability; Pseudomonas aeruginosa | 2010 |
In vitro efficacy of N-acetylcysteine on bacteria associated with chronic suppurative otitis media.
Topics: Acetylcysteine; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Ciprofloxacin; Dexamethasone; Drug Combinations; Drug Resistance, Microbial; Free Radical Scavengers; Humans; In Vitro Techniques; Otitis Media, Suppurative; Pseudomonas aeruginosa; Staphylococcus aureus | 2014 |
In vitro effects of N-acetyl cysteine alone and in combination with antibiotics on Prevotella intermedia.
Topics: Acetylcysteine; Ampicillin; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Metronidazole; Microbial Sensitivity Tests; Prevotella intermedia; Tetracycline | 2015 |
Effect of Antibiotics and Antibiofilm Agents in the Ultrastructure and Development of Biofilms Developed by Nonpigmented Rapidly Growing Mycobacteria.
Topics: Acetylcysteine; Amikacin; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Clarithromycin; Microbial Sensitivity Tests; Microscopy, Confocal; Mycobacterium; Polysorbates | 2016 |
N-acetylcysteine eradicates Pseudomonas aeruginosa biofilms in bone cement.
Topics: Acetylcysteine; Biofilms; Bone Cements; Ciprofloxacin; Microscopy, Electron, Scanning; Pseudomonas aeruginosa | 2016 |
N-acetylcysteine blocks SOS induction and mutagenesis produced by fluoroquinolones in Escherichia coli.
Topics: Acetylcysteine; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Microbial Sensitivity Tests; Mutagenesis; Mutation Rate; Reactive Oxygen Species; SOS Response, Genetics | 2019 |
Spray-drying of inhalable, multifunctional formulations for the treatment of biofilms formed in cystic fibrosis.
Topics: Acetylcysteine; Administration, Inhalation; Animals; Anti-Bacterial Agents; Azithromycin; Biofilms; Ciprofloxacin; Cystic Fibrosis; Drug Stability; Drug Storage; Expectorants; Horses; Mucus; Particle Size; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2019 |
Spray-dried multidrug particles for pulmonary co-delivery of antibiotics with N-acetylcysteine and curcumin-loaded PLGA-nanoparticles.
Topics: Acetylcysteine; Administration, Inhalation; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Ciprofloxacin; Curcumin; Cytokines; Drug Carriers; Drug Combinations; Drug Compounding; Expectorants; Freeze Drying; Humans; Inflammation Mediators; Macrophages; Microbial Viability; Mucus; Nanoparticles; Permeability; Polylactic Acid-Polyglycolic Acid Copolymer; Pseudomonas aeruginosa; Pseudomonas Infections; THP-1 Cells; Tobramycin | 2020 |
Effect of N-acetyl-L-cysteine on inflammation after intraperitoneal mesh placement in a potentially contaminated environment: An experimental study in the rat.
Topics: Acetylcysteine; Animals; Ciprofloxacin; Inflammation; Interleukin-6; Male; Rats; Rats, Wistar; Surgical Mesh; Tissue Adhesions | 2022 |
Impact of N-Acetylcysteine and Antibiotics Against Single and Dual Species Biofilms of Pseudomonas aeruginosa and Achromobacter xylosoxidans.
Topics: Acetylcysteine; Achromobacter denitrificans; Animals; Anti-Bacterial Agents; Aztreonam; Biofilms; Caenorhabditis elegans; Ciprofloxacin; Cystic Fibrosis; Humans; Pseudomonas aeruginosa; Tobramycin | 2022 |
Otologic safety of intratympanic N-acetylcysteine in an animal model.
Topics: Acetylcysteine; Animals; Ciprofloxacin; Dexamethasone; Guinea Pigs; Humans; Models, Animal; Ototoxicity | 2023 |